Variables | Neonates who survived (n = 145) | Neonates who died (n = 63) | Pvalue | ORuadj (95% CI) | ORadj (95% CI) |
---|---|---|---|---|---|
Maternal BMI, median (IQR) | 27.5 (25.0-30.1) | 25.6 (23.0-29.4) | 0.06 | 0.91 (0.83-1.00) | 1.05 (0.91-1.23) |
Maternal Age, median years (IQR) | 24.4 (20.9-27.9) | 25.3 (22.5-28.6) | 0.57 | 1.02 (0.96-1.08) | Â |
Gestational age | |||||
Non-premature delivery (≥ 37 weeks) | 76/145 (52.4) | 12/63 (19.0) |  | Referent | Referent |
Preterm delivery (< 37 weeks) | 69/145 (47.6) | 51/63 (81.0) | < 0.001 | 4.68 (2.31-9.51) | 4.17 (1.19-14.56) |
Comorbidities ** (%) | 16/145 (11.0) | 3 (4.8) | 0.15 | 0.40 (0.11-1.44) | Â |
Symptoms and Lab findings | |||||
CNS symptom (%) | 10/145 (6.9) | 13/63 (20.6) | 0.005 | 3.51 (1.45-8.51) | 0.85 (0.08-9.47) |
AST (u/L), median (IQR) | 40 (26-76) | 73 (36-139) | 0.01 | 1.00 (1.00-1.01) | 1.00 (0.99-1.01) |
PaO2/FiO2 on admission | |||||
PaO2/FiO2 ≥ 300 (%) | 61/161 (37.9) | 2/58 (3.4) |  | Referent | Referent |
PaO2/FiO2 201 to 300 (%) | 22/161 (13.7) | 3/58 (5.2) | 0.13 | 4.16 (0.65-26.57) | 3.59 (0.11-121.48) |
PaO2/FiO2 ≤ 200 (%) | 78/161 (48.4) | 53/58 (91.4) | < 0.001 | 20.72 (4.86-88.44) | 12.33 (0.86-177.49) |
APACHE II score, median (IQR) | 8 (5-12) | 10 (5-14) | 0.17 | 1.04 (0.98-1.09) | 0.99 (0.87-1.14) |